Risk of multiple myeloma in a case–spouse study

References

• Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277–300.
   PubMed Web of Science ®Google Scholar
• Kumar SK, Rajkumar SV, Dispenzieri, et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood 2008; 111: 2516–2520.
   PubMed Web of Science ®Google Scholar
• Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2011. Bethesda, MD National Cancer Institute; Available from: http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER website, April 2014.
   Google Scholar
• Baris D, Brown LM, Andreotti G, et al. Epidemiology of multiple myeloma. In: Wiernik PH, Goldman JM, Dutcher JP, et al, editors. Neoplastic diseases of the blood. New York: Springer; 2013. p 547–564.
   Google Scholar
• Robins J, Pike M. The validity of case-control studies with nonrandom selection of controls. Epidemiology 1990; 1: 273–284.
   PubMedGoogle Scholar
• Wacholder S, McLaughlin JK, Silverman DT, et al. Selection of controls in case-control studies. I. Principles. Am J Epidemiol 1992; 135: 1019–1028.
   PubMed Web of Science ®Google Scholar
• Wacholder S, Silverman DT, McLaughlin JK, et al. Selection of controls in case-control studies. II. Types of controls. Am J Epidemiol 1992; 135: 1029–1041.
   PubMed Web of Science ®Google Scholar
• Van Ness B, Ramos C, Haznadar M, et al. Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival. BMC Med 2008; 6: 26.
   PubMed Web of Science ®Google Scholar
• US Department of Commerce. Standard occupational classification manual. Washington, DC: Office of Federal Statistical Policy and Standards; 1980.
   Google Scholar
• Mills PK, Newell GR, Beeson WL, et al. History of cigarette smoking and risk of leukemia and myeloma: results from the Adventist health study. J Natl Cancer Inst 1990; 82: 1832–1836.
   PubMed Web of Science ®Google Scholar
• Flodin U, Fredriksson M, Persson B. Multiple myeloma and engine exhausts, fresh wood, and creosote: a case-referent study. Am J Ind Med 1987; 12: 519–529.
   PubMed Web of Science ®Google Scholar
• Vlajinac HD, Pekmezović TD, Adanja BJ, et al. Case-control study of multiple myeloma with special reference to diet as risk factor. Neoplasma 2003; 50: 79–83.
   PubMed Web of Science ®Google Scholar
• Heineman EF, Zahm SH, McLaughlin JK, et al. A prospective study of tobacco use and multiple myeloma: evidence against an association. Cancer Causes Control 1992; 3: 31–36.
   PubMed Web of Science ®Google Scholar
• Linet MS, McLaughlin JK, Hsing AW, et al. Is cigarette smoking a risk factor for non-Hodgkin's lymphoma or multiple myeloma? Results from the Lutheran Brotherhood Cohort Study. Leuk Res 1992; 16: 621–624.
   PubMed Web of Science ®Google Scholar
• Friedman GD. Cigarette smoking, leukemia, and multiple myeloma. Ann Epidemiol 1993; 3: 425–428.
   PubMedGoogle Scholar
• Adami J, Nyrén O, Bergström R, et al. Smoking and the risk of leukemia, lymphoma, and multiple myeloma (Sweden). Cancer Causes Control 1998; 9: 49–56.
   PubMed Web of Science ®Google Scholar
• Castillo JJ, Dhami PK, Curry S, et al. No association between cigarette smoking and incidence of plasma cell myeloma: a meta-analysis of 17 observational studies. Am J Hematol 2012; 87: 729–731.
   PubMed Web of Science ®Google Scholar
• Psaltopoulou T, Sergentanis TN, Kanellias N, et al. Tobacco smoking and risk of multiple myeloma: a meta-analysis of 40 observational studies. Int J Cancer 2013; 132: 2413–2431.
   PubMed Web of Science ®Google Scholar
• Andreotti G, Birmann BM, Cozen W, et al. A pooled analysis of cigarette smoking and risk of multiple myeloma in the International Multiple Myeloma Consortium. CEBP. 2015; 24: 631–634.
   Google Scholar
• Sopori ML, Kozak W. Immunomodulatory effects of cigarette smoke. J Neuroimmunol 1998; 83: 148–156.
   PubMed Web of Science ®Google Scholar
• IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 2004; 83: 1–1438.
   PubMedGoogle Scholar
• Andreotti G, Birmann B, De Roos AJ, et al. A pooled analysis of alcohol consumption and risk of multiple myeloma in the International Multiple Myeloma Consortium. Cancer Epidemiol Biomarkers Prev 2013; 22: 1620–1627.
   PubMed Web of Science ®Google Scholar
• Chang ET, Clarke CA, Canchola AJ, et al. Alcohol consumption over time and risk of lymphoid malignancies in the California Teachers Study cohort. Am J Epidemiol 2010; 172: 1373–1383.
   PubMed Web of Science ®Google Scholar
• Kanda J, Matsuo K, Inoue M, et al. Association of alcohol intake with the risk of malignant lymphoma and plasma cell myeloma in Japanese: a population-based cohort study (Japan Public Health Center–based Prospective Study). Cancer Epidemiol Biomarkers Prev 2010; 19: 429–434.
   PubMed Web of Science ®Google Scholar
• Szabo G, Mandrekar P, Girouard L, et al. Regulation of human monocyte functions by acute ethanol treatment: decreased tumor necrosis factor-alpha, interleukin-1 beta and elevated interleukin–10, and transforming growth factor-beta production. Alcohol Clin Exp Res 1996; 20: 900–907.
   PubMed Web of Science ®Google Scholar
• Smedby KE, Askling J, Mariette X, et al. Autoimmune and inflammatory disorders and risk of malignant lymphomas–an update. J Intern Med 2008; 264: 514–527.
   PubMed Web of Science ®Google Scholar
• Díaz LE, Montero A, González-Gross M, et al. Influence of alcohol consumption on immunological status: a review. Eur J Clin Nutr 2002; 56: S50–53.
   PubMed Web of Science ®Google Scholar
• Larsson SC, Wolk A. Body mass index and risk of multiple myeloma: a meta-analysis. Int J Cancer 2007; 121: 2512–2516.
   PubMed Web of Science ®Google Scholar
• Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569–578.
   PubMed Web of Science ®Google Scholar
• Britton JA, Khan AE, Rohrmann S, et al. Anthropometric characteristics and non-Hodgkin's lymphoma and multiple myeloma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Haematologica 2008; 93: 1666–1677.
   PubMed Web of Science ®Google Scholar
• Pylypchuk RD, Schouten LJ, Goldbohm RA, et al. Body mass index, height, and risk of lymphatic malignancies: a prospective cohort study. Am J Epidemiol 2009; 170: 297–307.
   PubMed Web of Science ®Google Scholar
• Soderberg KC, Kaprio J, Verkasalo PK, et al. Overweight, obesity and risk of haematological malignancies: a cohort study of Swedish and Finnish twins. Eur J Cancer 2009; 45: 1232–1238.
   PubMed Web of Science ®Google Scholar
• Lauta VM. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications. Cancer 2003; 97: 2440–2452.
   PubMed Web of Science ®Google Scholar
• Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immun 2006; 6: 772–783.
   PubMed Web of Science ®Google Scholar
• Hofmann JN, Liao LM, Pollak MN, et al. A prospective study of circulating adipokine levels and risk of multiple myeloma. Blood 2012; 120: 4418–4420.
   PubMed Web of Science ®Google Scholar
• Gold LS, Milliken K, Stewart P, et al. Occupation and multiple myeloma: an occupation and industry analysis. Am J Ind Med 2010; 53: 768–779.
   PubMed Web of Science ®Google Scholar
• Petralia SA, Dosemeci M, Adams EE, et al. Cancer mortality among women employed in health care occupations in 24 U.S. states, 1984–1993. Am J Ind Med 1999; 36: 159–165.
   PubMed Web of Science ®Google Scholar
• Lee WJ, Baris D, Järvholm B, et al. Multiple myeloma and diesel and other occupational exposures in swedish construction workers. Int J Cancer 2003; 107: 134–138.
   PubMed Web of Science ®Google Scholar
• Alexander DD, Mink PJ, Adami HO, et al. Multiple myeloma: a review of the epidemiologic literature. Int J Cancer. 2007; 12: 40–61.
   Web of Science ®Google Scholar
• Lewtas J. Mutagenic activity of diesel emissions. Dev Toxicol Environ Sci 1982; 10: 243–264.
   PubMedGoogle Scholar
• Pereira MA. Genotoxicity of diesel exhaust emissions in laboratory animals. Dev Toxicol Environ Sci 1982; 10: 265–276.
   PubMedGoogle Scholar
• IARC: diesel engine exhaust carcinogenic. Cent Eur J Public Health 2012; 20: 120–138.
   PubMed Web of Science ®Google Scholar
• Heineman EF, Olsen JH, Pottern LM, et al. Occupational risk factors for multiple myeloma among Danish men. Cancer Causes Control 1992; 3: 555–568.
   PubMed Web of Science ®Google Scholar
• Nanni O, Falcini F, Buiatti E, et al. Multiple myeloma and work in agriculture: results of a case-control study in Forlì, Italy. Cancer Causes Control 1998; 9: 277–283.
   PubMed Web of Science ®Google Scholar
• Brown LM, Gridley G, Check D, et al. Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders. Blood 2008; 111: 3388–3394.
   PubMed Web of Science ®Google Scholar
• Lindqvist EK, Goldin LR, Landgren O, et al. Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study. Blood 2011; 118: 6284–6291.
   PubMed Web of Science ®Google Scholar
• Gramenzi A, Buttino I, D'Avanzo B, et al. Medical history and the risk of multiple myeloma. Br J Cancer 1991; 63: 769–772.
   PubMed Web of Science ®Google Scholar
• Lewis DR, Pottern LM, Brown LM, et al. Multiple myeloma among blacks and whites in the United States: the role of chronic antigenic stimulation. Cancer Causes Control 1994; 5: 529–539.
   PubMed Web of Science ®Google Scholar
• Landgren O, Zhang Y, Zahm SH, et al. Risk of multiple myeloma following medication use and medical conditions: a case-control study in Connecticut women. Cancer Epidemiol Biomarkers Prev 2006; 15: 2342–2347.
   PubMed Web of Science ®Google Scholar
• Landgren O, Rapkin JS, Mellemkjaer L, et al. Respiratory tract infections in the pathway to multiple myeloma: a population-based study in Scandinavia. Haematologica 2006; 91: 1697–1700.
   PubMed Web of Science ®Google Scholar
• Rajkumar SV. MGUS and smoldering multiple myeloma: update on pathogenesis, natural history, and management. Hematology Am Soc Hematol Educ Program 2005; 340–345.
   PubMedGoogle Scholar
• Kristinsson SY, Tang M, Pfeiffer RM, et al. Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study. Haematologica 2012; 97: 854–858.
   PubMed Web of Science ®Google Scholar
• Costa DB, Shin B, Cooper DL. Pneumococcemia as the presenting feature of multiple myeloma. Am J Hematol 2004; 77: 277–281.
   PubMed Web of Science ®Google Scholar
• Gallagher RP, Spinelli JJ, Elwood JM, et al. Allergies and agricultural exposure as risk factors for multiple myeloma. Br J Cancer 1983; 48: 853–857.
   PubMed Web of Science ®Google Scholar
• Pearce NE, Smith AH, Howard JK, et al. Case-control study of multiple myeloma and farming. Br J Cancer 1986; 54: 493–500.
   PubMed Web of Science ®Google Scholar
• Svec MA, Ward MH, Dosemeci M, et al. Risk of lymphatic or haematopoietic cancer mortality with occupational exposure to animals or the public. Occup Environ Med 2005; 62: 726–735.
   PubMed Web of Science ®Google Scholar
• Pahwa P, Karunanayake CP, Dosman JA, et al. Multiple myeloma and exposure to pesticides: a Canadian case-control study. J Agromedicine 2012; 17: 40–50.
   PubMed Web of Science ®Google Scholar
• Zidan A, Scheuerlein H, Schüle S, et al. Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in Iran and worldwide. Hepat Mon 2012; 12: e6894.
   PubMedGoogle Scholar
• Khan AE, Gallo V, Linseisen J, et al. Diabetes and the risk of non-Hodgkin's lymphoma and multiple myeloma in the European Prospective Investigation into Cancer and Nutrition. Haematologica 2008; 93: 842–850.
   PubMed Web of Science ®Google Scholar
• Chiu BC, Gapstur SM, Greenland P, et al. Body mass index, abnormal glucose metabolism, and mortality from hematopoietic cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 2348–2354.
   PubMed Web of Science ®Google Scholar
• Dimitroulakos J, Nohynek D, Backway KL, et al. Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: a potential therapeutic approach. Blood 1999; 93: 1308–1318.
   PubMed Web of Science ®Google Scholar
• Buchwald H. Cholesterol inhibition, cancer, and chemotherapy. Lancet 1992; 339: 1154–1156.
   PubMed Web of Science ®Google Scholar
• Durie B, Mundy G. Statin use and the likelihood of bone disease in newly diagnosed myeloma. Blood (Suppl) 2002; 100: 5097.
   Google Scholar
• Mundy G, Garrett R, Harris S, et al. Stimulation of bone formation in vitro and in rodents by statins. Science 1999; 286: 1946–1949.
   PubMed Web of Science ®Google Scholar
• Lee WC. Genetic association studies of adult-onset diseases using the case-spouse and case-offspring designs. Am J Epidemiol 2003; 158: 1023–1032.
   PubMed Web of Science ®Google Scholar
• Verhage BA, Aben KK, Straatman H, et al. Spouse controls in family case-control studies: a methodological consideration. Fam Cancer 2003; 2: 101–108.
   PubMedGoogle Scholar
• Jiang J, Liu B, Sitas F, et al. Case-spouse control design in practice: an experience in estimating smoking and chronic obstructive pulmonary disease deaths in Chinese adults. J Formos Med Assoc 2010; 109: 369–377.
   PubMed Web of Science ®Google Scholar
• Allison DB, Neale MC, Kezis MI, et al. Assortative mating for relative weight: genetic implications. Behav Genet 1996; 26: 103–111.
   PubMed Web of Science ®Google Scholar
• Botwin MD, Buss DM, Shackelford TK. Personality and mate preferences: five factors in mate selection and marital satisfaction. J Pers 1997; 65: 107–136.
   PubMed Web of Science ®Google Scholar
• Lynch HT, Sanger WG, Pirruccello S, et al. Familial multiple myeloma: a family study and review of the literature. J Natl Cancer Inst 2001; 93: 1479–1483.
   PubMed Web of Science ®Google Scholar
• Baris D, Brown LM, Silverman DT, et al. Socioeconomic status and multiple myeloma among US blacks and whites. Am J Public Health 2000; 90: 1277–1281.
   PubMed Web of Science ®Google Scholar
• Koutros S, Baris D, Bell E, et al. Use of hair colouring products and risk of multiple myeloma among US women. Occup Environ Med 2009; 66: 68–70.
   PubMed Web of Science ®Google Scholar